Changes of 2-deoxyglucose uptake in the rat auditory pathway after bilateral ablation of the cochlea.
It has been reported that the area of decreased glucose metabolism in the FDG-PET of prelingually deaf children correlates significantly with speech performance after cochlear implantation. In this study, we undertook to confirm changes of glucose metabolism in the cerebral cortex using an animal model with age-matching groups to completely exclude the influence of age differences between the deaf and normal-hearing groups. The cochlea was ablated bilaterally at a postnatal 10-14 days in the deaf groups; 3-4 deaf and normal rats were included at each time point at 1, 2, 4 and 8 weeks and 7 months after ablation. After injecting 2-deoxyglucose intraperitoneally, digitalized autoradiographic images were obtained, and analyzed by using two different methods; 3-dimensional voxel-wise statistical analysis and conventional 2-dimensional densitometry. The hypometabolic area analyzed using 3-dimensional analysis and the differences of optical density between normal and deaf as determined by densitometry were widest and most prominent between 4 and 8 weeks after ablation. Differences were not significant before 2 weeks or after 7 months after ablation. This result shows that the hypometabolic area becomes prominent after a critical period and it decreases as the duration of deafness increases. We believe that cross-modal plasticity may be the mechanism of changes in glucose metabolism and that this result reinforced the usefulness of evaluating hypometabolic area using FDG-PET in deaf children.
Department of Otolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea.
S H
SH
Ahn
S H
SH
Oh
J S
JS
Lee
J M
JM
Jeong
D
D
Lim
D S
DS
Lee
C S
CS
Kim
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000378:metabolism; D001303:Auditory Cortex / Q000378:metabolism; D001306:Auditory Pathways / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000503:physiopathology; D001345:Autoradiography; D002540:Cerebral Cortex / Q000378:metabolism; D003638:Deafness / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000503:physiopathology; D003720:Densitometry; D003847:Deoxyglucose / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001330:Electronic Data Processing; D019788:Fluorodeoxyglucose F18; D005829:Geniculate Bodies / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D007245:Inferior Colliculi / Q000378:metabolism; D007274:Injections, Intraperitoneal; D009473:Neuronal Plasticity; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D051381:Rats; D017207:Rats, Sprague-Dawley
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose